Thursday, October 15, 2020

Russia approves 2nd coronavirus vaccine after early trials

The peptide-based, two-shot vaccine, EpiVacCorona, was developed by the Vector Institute in Siberia

from The Hindu - International https://ift.tt/3nTdJJe
on
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)